Brief: Bionaturis in consortium to develop biopharmaceuticals

Biotechnology Assets SA

28/12/2015 07:22

Dec 28 (Reuters) - Bioorganic Research and Services SA 
 BNT.MC : 
    * Says it will take part in consortium BIOMAP to design 
tests and to develop biopharmaceuticals 
    * Says to get subsidy of 572,988 euros ($627,938) for the 
initiative 
    * Says BIOMAP, composed of Laboratorios ROVI  ROVI.MC , 
Bionaturis, Vaxdyn and Vivacell Biotechnology Espana will be 
developed between 2015-2017 
 
 
Source text: http://bit.ly/1IxZP8P 
     
Further company coverage:  BNT.MC  
 
($1 = 0.9125 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))